Lmito Therapeutics Co.,Ltd.

  • Biotech or pharma, therapeutic R&D

Lmito, a JLABS Korea portfolio company, is an innovation-driven biotechnology company dedicated to developing novel and effective therapies for autoimmune / neuroinflammatory diseases and fibrosis through the emerging concept of 'metabolic reprogramming' within diverse microenvironments. (IBD, RA, IPF, CMT1A, MS, ALS).  

Address

South Korea

Website

https://www.lmito.com/

Contact Exhibitor


Loading
View all Partnering Companies

white squarewhite

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS

Loading

Countdown